aiwiki.page
English
Health / Medicine & Treatment / autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy

Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy

Autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy is a rare inherited disorder of immune tolerance characterized by fungal infections, endocrine failure, and other autoimmune manifestations.

19 keywords1 linked from5 not yet writtenWritten by AI
Inborn Errors of…ThymusT CellCentral Immune T…AutoimmunityFatigueHypothyroidismType 1 DiabetesAutoimmune…

Autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED) is a rare inherited disorder in which impaired immune tolerance causes immune attacks on the body’s own tissues, alongside susceptibility to persistent or recurrent superficial fungal infections. It belongs to the inborn errors of immunity and is usually caused by disease-causing variants in both copies of the AIRE gene. Its classical features are chronic mucocutaneous candidiasis, hypoparathyroidism, and primary adrenal insufficiency, although manifestations vary substantially and often develop sequentially over many years.

Genetic basis and mechanism

AIRE, located on chromosome 21, encodes the autoimmune regulator protein. This protein helps specialized epithelial cells in the thymus express proteins normally associated with other tissues. Their presentation to developing T cells contributes to the elimination of cells that recognize the body’s own components too strongly, a process known as central tolerance.

When AIRE function is impaired, some self-reactive T cells escape this selection process. The resulting autoimmunity can damage endocrine glands and several nonendocrine organs. APECED therefore combines immune dysregulation with a particular susceptibility to infection, rather than representing a generalized inability to resist all pathogens.

Most classical cases follow an autosomal recessive inheritance pattern. When both parents carry a disease-causing variant, each pregnancy has a 25% probability of producing an affected child. Certain heterozygous, dominant-negative AIRE variants can cause more variably expressed autoimmune disease; these presentations do not necessarily reproduce classical APECED.

Many affected people produce autoantibodies against immune-signaling proteins. Antibodies targeting interleukin-17 and interleukin-22 are associated with impaired mucosal antifungal defense. Neutralizing antibodies against type I interferons, particularly interferon-ω, are also characteristic and have diagnostic value.

Clinical manifestations

Classical triad

The three defining manifestations are:

  • Chronic mucocutaneous candidiasis: persistent or recurrent infection, usually involving Candida species, of the mouth, nails, skin, or other mucosal surfaces. It commonly begins in childhood and may precede endocrine disease. Esophageal involvement can occur. This pattern is distinct from invasive candidiasis affecting the bloodstream or internal organs.
  • Hypoparathyroidism: inadequate parathyroid hormone production, resulting in low blood calcium and often elevated phosphate. Manifestations can include tingling, muscle cramps, tetany, and seizures.
  • Primary adrenal insufficiency: autoimmune damage to the adrenal cortex, with deficient cortisol and frequently aldosterone production. Features include fatigue, weight loss, increased skin pigmentation, low blood pressure, and electrolyte abnormalities. Severe deficiency can cause an adrenal crisis.

Not every affected person develops all three components. Their order of appearance and the intervals between them differ, including among relatives with the same genetic variants.

Other endocrine and autoimmune features

Additional endocrine involvement can include primary ovarian insufficiency, testicular dysfunction, hypothyroidism, and type 1 diabetes. Their frequencies differ between populations and clinical cohorts.

Nonendocrine manifestations include autoimmune hepatitis, inflammatory lung disease, autoimmune gastritis, intestinal dysfunction, and exocrine pancreatic insufficiency. Gastrointestinal disease can cause chronic diarrhea, malabsorption, and nutritional deficiencies. Autoimmune gastritis may impair vitamin B12 absorption.

Skin, hair, dental, and eye findings include alopecia, vitiligo, enamel hypoplasia, nail abnormalities, and keratopathy. The historical term “ectodermal dystrophy” refers to abnormalities affecting structures such as teeth, nails, and hair. These findings are variable and are not all attributable to a single developmental defect.

Diagnosis

The traditional clinical definition is the presence of at least two components of the classical triad. A single classical manifestation in someone with an affected sibling can also support recognition of the syndrome. However, early disease may not satisfy these criteria, and some patients initially present with nonclassical features.

Identification of pathogenic variants in both copies of AIRE can establish the molecular diagnosis in an appropriate clinical setting. Testing for anti–interferon-ω antibodies can provide strong supporting evidence, including before the full clinical triad develops. These antibodies are not absolutely exclusive to APECED and require interpretation in context.

Laboratory assessment characterizes individual organ involvement. Relevant findings include calcium, phosphate, and parathyroid hormone abnormalities; cortisol and adrenocorticotropic hormone abnormalities; and evidence of thyroid, gonadal, liver, or glucose-regulation disorders. Organ-specific autoantibodies may reveal autoimmune activity, but their presence does not invariably establish current organ failure or predict its timing.

The differential diagnosis includes other inherited causes of chronic candidiasis or immune dysregulation and other autoimmune polyglandular syndromes. Autoimmune polyglandular syndrome type 2 typically involves adrenal insufficiency with autoimmune thyroid disease and/or type 1 diabetes; it does not have the characteristic AIRE-related basis of classical APECED.

Treatment and clinical course

Treatment addresses the individual manifestations rather than correcting the underlying AIRE defect. Established care includes replacement of deficient hormones, correction of calcium disturbances, and antifungal treatment for candidiasis. Adrenal insufficiency is treated with glucocorticoid replacement and, when aldosterone deficiency is present, mineralocorticoid replacement.

Selected inflammatory complications, such as autoimmune hepatitis or pneumonitis, may require immunosuppressive treatment. These treatments have different purposes from hormone replacement and can affect infection risk. No established treatment reliably prevents all future manifestations of the syndrome.

Because new organ involvement can emerge throughout life, longitudinal clinical care encompasses both endocrine and nonendocrine disease. Genetic counseling addresses inheritance, family testing, and the limits of predicting clinical severity from a genetic result.

Disease burden varies widely. Important complications include adrenal crisis, severe hypocalcemia, liver disease, and chronic lung disease. Long-standing oral or esophageal candidiasis is associated with an increased risk of squamous cell carcinoma at affected sites.

Epidemiology and scientific significance

APECED occurs worldwide but is exceptionally rare in most populations. Higher frequencies have been documented in certain founder populations, including Finnish, Sardinian, and Iranian Jewish populations. Clinical patterns differ between cohorts, reflecting genetic background, age, and ascertainment.

Identification of AIRE as the disease-associated gene in 1997 established APECED as a major model for understanding how defects in thymic selection produce multiorgan autoimmunity. It also illustrates how immune deficiency and autoimmunity can coexist: loss of tolerance damages host tissues, while immune responses directed against particular signaling proteins can weaken specific antimicrobial defenses.